Found: 705
Select item for more details and to access through your institution.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure
- Published in:
- 2003
- By:
- Publication type:
- journal article
Short-term Mortality Risk in Emergency Department Acute Heart Failure.
- Published in:
- Academic Emergency Medicine, 2011, v. 18, n. 9, p. 947, doi. 10.1111/j.1553-2712.2011.01150.x
- By:
- Publication type:
- Article
Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure.
- Published in:
- Wiener Klinische Wochenschrift, 2016, v. 128, p. 497, doi. 10.1007/s00508-016-1112-8
- By:
- Publication type:
- Article
Publication trends in cachexia and sarcopenia in elderly heart failure patients.
- Published in:
- Wiener Klinische Wochenschrift, 2016, v. 128, p. 446, doi. 10.1007/s00508-016-1126-2
- By:
- Publication type:
- Article
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 7, p. 738, doi. 10.1002/pds.3789
- By:
- Publication type:
- Article
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.13191
- By:
- Publication type:
- Article
Vorhofflimmerndiagnostik mittels EKG-fähiger Smartwatches.
- Published in:
- Der Nervenarzt, 2022, v. 93, n. 2, p. 175, doi. 10.1007/s00115-021-01124-x
- By:
- Publication type:
- Article
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 246, doi. 10.1007/s00125-023-06031-1
- By:
- Publication type:
- Article
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.
- Published in:
- Cerebrovascular Diseases, 2017, v. 44, n. 1/2, p. 43, doi. 10.1159/000474958
- By:
- Publication type:
- Article
Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factor.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 5, p. 903, doi. 10.1002/ehf2.12540
- By:
- Publication type:
- Article
Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 5, p. 1077, doi. 10.1002/ehf2.12496
- By:
- Publication type:
- Article
Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 4, p. 621, doi. 10.1002/ehf2.12462
- By:
- Publication type:
- Article
Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 2, p. 297, doi. 10.1002/ehf2.12407
- By:
- Publication type:
- Article
Cardiac expression of neutrophil gelatinase‐associated lipocalin in a model of cancer cachexia‐induced cardiomyopathy.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 1, p. 89, doi. 10.1002/ehf2.12372
- By:
- Publication type:
- Article
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 5, p. 800, doi. 10.1002/ehf2.12331
- By:
- Publication type:
- Article
Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3‐left ventricular hypertrophy (Beta3‐LVH)
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 5, p. 830, doi. 10.1002/ehf2.12306
- By:
- Publication type:
- Article
Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 4, p. 549, doi. 10.1002/ehf2.12345
- By:
- Publication type:
- Article
Muscle wasting and sarcopenia in heart failure and beyond: update 2017.
- Published in:
- ESC Heart Failure, 2017, v. 4, n. 4, p. 492, doi. 10.1002/ehf2.12237
- By:
- Publication type:
- Article
Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF).
- Published in:
- ESC Heart Failure, 2017, v. 4, n. 4, p. 448, doi. 10.1002/ehf2.12209
- By:
- Publication type:
- Article
Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis.
- Published in:
- ESC Heart Failure, 2017, v. 4, n. 4, p. 402, doi. 10.1002/ehf2.12204
- By:
- Publication type:
- Article
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2578, doi. 10.1111/dom.15572
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
- By:
- Publication type:
- Article
Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 4, p. 662, doi. 10.1111/dom.14626
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
The randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided antibiotic Therapy after Stroke.
- Published in:
- Frontiers in Neurology, 2017, v. 8, p. 1, doi. 10.3389/fneur.2017.00153
- By:
- Publication type:
- Article
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.
- Published in:
- Nutrients, 2021, v. 13, n. 1, p. 257, doi. 10.3390/nu13010257
- By:
- Publication type:
- Article
Preserved Skeletal Muscle Mitochondrial Function, Redox State, Inflammation and Mass in Obese Mice with Chronic Heart Failure.
- Published in:
- Nutrients, 2020, v. 12, n. 11, p. 3393, doi. 10.3390/nu12113393
- By:
- Publication type:
- Article
A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure.
- Published in:
- Nutrients, 2020, v. 12, n. 9, p. 2541, doi. 10.3390/nu12092541
- By:
- Publication type:
- Article
Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02328-6
- By:
- Publication type:
- Article
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01943-z
- By:
- Publication type:
- Article
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.
- Published in:
- Heart Failure Reviews, 2014, v. 19, n. 2, p. 135, doi. 10.1007/s10741-012-9361-8
- By:
- Publication type:
- Article
Anemia in chronic heart failure: Can we treat? What to treat?
- Published in:
- Heart Failure Reviews, 2012, v. 17, n. 2, p. 203, doi. 10.1007/s10741-011-9283-x
- By:
- Publication type:
- Article
Metabolic and immunologic derangements in cardiac cachexia: where to from here?
- Published in:
- Heart Failure Reviews, 2006, v. 11, n. 1, p. 57, doi. 10.1007/s10741-006-9193-5
- By:
- Publication type:
- Article
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
- Published in:
- EP: Europace, 2023, v. 25, n. 4, p. 1249, doi. 10.1093/europace/euac123
- By:
- Publication type:
- Article
Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
- Published in:
- 2019
- By:
- Publication type:
- journal article